Century Therapeutics Inc (IPSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 148 | 99 | 1,720 | 521 | 2,224 |
| Gross Profit | 148 | 99 | 1,720 | 521 | 2,224 |
| Operating Expenses | 35,774 | 35,176 | 33,801 | 33,827 | 33,962 |
| Operating Income | -35,626 | -35,077 | -32,081 | -33,306 | -31,738 |
| Interest Expense | 0 | 136 | 404 | 413 | 373 |
| Other Income | 3,498 | 2,872 | 2,429 | 2,069 | 1,387 |
| Pre-tax Income | -32,128 | -32,341 | -30,056 | -31,650 | -30,724 |
| Income Tax | 592 | 950 | 1,208 | 32 | 25 |
| Net Income Continuous | -32,720 | -33,291 | -31,264 | -31,682 | -30,749 |
| Net Income | $-32,720 | $-33,291 | $-31,264 | $-31,682 | $-30,749 |
| EPS Basic Total Ops | -0.55 | -0.56 | -0.53 | -0.54 | -0.53 |
| EPS Basic Continuous Ops | -0.55 | -0.56 | -0.53 | -0.54 | -0.53 |
| EPS Diluted Total Ops | -0.55 | -0.56 | -0.53 | -0.54 | -0.53 |
| EPS Diluted Continuous Ops | -0.55 | -0.56 | -0.53 | -0.54 | -0.53 |
| EBITDA(a) | $-32,276 | $-31,805 | $-29,117 | $-30,399 | $-28,886 |